Elsevier

IJC Heart & Vasculature

Volume 11, June 2016, Pages 29-34
IJC Heart & Vasculature

Using MRI to predict future adverse cardiac remodelling in a male mouse model of myocardial infarction

https://doi.org/10.1016/j.ijcha.2016.03.005Get rights and content
Under a Creative Commons license
open access

Abstract

Background

Mice are frequently used in research to examine outcomes of myocardial infarction (MI) and to investigate therapeutic interventions at an early pre-clinical stage. The MI model is generated by surgically occluding a major coronary artery, but natural variation in murine coronary anatomy can generate variable outcomes that will inevitably affect the accuracy of such investigations. The aim of this study was to use MRI to derive the most sensitive early variable that could be used to predict subsequent adverse cardiac remodelling in a male mouse model of MI.

Methods

Using a longitudinal study design, heart structure and function were evaluated using cardiac MRI at one week following surgical MI to generate the early measurements and again at four weeks, when the scar had matured. The primary variables measured at week one were left ventricular volumes at end systole (LV-ESV) and at end diastole (LV-EDV), infarct size, LV-cardiac mass, and ejection fraction (EF).

Results

Univariate and multiple regression analyses showed that LV-ESV at one week following MI could be used to accurately predict various parameters of adverse LV remodelling at four weeks post-MI. However, the highest correlation was between LV-ESV at one week following MI and LV-EDV at four weeks (r = 0.99; p < 0.0001), making LV-ESV at one week a valuable predictor variable of future adverse ventricular remodelling after MI.

Conclusion

Using MRI to determine LV-ESV at an early stage following MI enables a more robust analysis of potential therapeutic interventions to ameliorate adverse cardiac remodelling.

Keywords

Myocardial infarction
Animal models of human disease
Remodelling
MRI

Cited by (0)

1

Joint first authors.

2

This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

3

Currently at Castle Hill Hospital, Castle Road, Cottingham, HU16 5JQ, UK.